Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Chakkarin BurudpakdeeIMS Health, Fairfax, VA, USA; ;University of North Carolina at Charlotte, Charlotte, NC, USA; Correspondence[email protected]

Huamao Mark LinMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Weiying WangNucleusX Market Access, Warren, NJ, USA;

Arpamas SeetasithIMS Health, Fairfax, VA, USA;

Yanyan ZhuMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Vijayveer BonthapallyMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Kenneth R. CarsonWashington University School of Medicine, St. Louis, MO, USA

show all

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Allison A. Petrilla, Anne Shah, Joseph Feliciano, Joseph Woolery & Thomas W. LeBlanc. (2021) Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting. Current Medical Research and Opinion 37:7, pages 1189-1197.
Read now

Articles from other publishers (5)

Marjan ZakeriJieni LiSujit S SansgiryRajender R Aparasu. (2023) Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data. Journal of Managed Care & Specialty Pharmacy 29:5, pages 480-489.
Crossref

Ajibade O Ashaye, Heather Burnett, Seye Abogunrin, Hemangi Panchmatia, Olga Ovcinnikova & Mehul Dalal. (2022) The clinical and economic burden of peripheral T-cell lymphoma: a systematic literature review. Future Oncology 18:4, pages 519-535.
Crossref

Virginie Nerich, Christophe Guyeux, Michel Henry‐Amar, Raphaël Couturier, Catherine Thieblemont, Vincent Ribrag, Hervé Tilly, Corinne Haioun, René‐Olivier Casasnovas, Franck Morschhauser, Pierre Feugier, David Sibon, Loic Ysebaert, Emmanuelle Nicolas‐Virelizier, Florence Broussais‐Guillaumot, Gandhi L. Damaj, Jean‐Philippe Jais, Gilles Salles, Macha Woronoff‐Lemsi & Nicolas Mounier. (2021) Economic burden in non‐Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross‐sectional study. Cancer 128:3, pages 519-528.
Crossref

G. Fossard, F. Broussais, I. Coelho, S. Bailly, E. Nicolas-Virelizier, E. Toussaint, C. Lancesseur, F. Le Bras, E. Willems, E. Tchernonog, T. Chalopin, R. Delarue, R. Gressin, A. Chauchet, E. Gyan, G. Cartron, C. Bonnet, C. Haioun, G. Damaj, P. Gaulard, L. Fornecker, H. Ghesquières, O. Tournilhac, M. Gomes da Silva, R. Bouabdallah, G. Salles & E. Bachy. (2018) Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Annals of Oncology 29:3, pages 715-723.
Crossref

Tatyana Feldman, Charles M. Farber, Kelly Choi, Claudio Faria, Andre Goy, Jacqueline Connors, Dhakshila Paramanathan, Sukhi Kaur, Eric Schultz, Michael McGuire & Stuart L. Goldberg. (2017) Treatment of Peripheral T-Cell Lymphoma in Community Settings. Clinical Lymphoma Myeloma and Leukemia 17:6, pages 354-361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Citations (6)

Read on this site (1)

Articles from other publishers (5)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date